END STAGE RENAL DISEASE

This adverse event was reported 6949 times

These drugs are most commonly taken by patients reporting END STAGE RENAL DISEASE:

# Drug Count
0 ESOMEPRAZOLE MAGNESIUM 4554
1 ESOMEPRAZOLE SODIUM 4489
2 LANSOPRAZOLE 4382
3 OMEPRAZOLE MAGNESIUM 4087
4 PANTOPRAZOLE SODIUM 3624
5 DEXLANSOPRAZOLE 2990
6 RABEPRAZOLE SODIUM 899
7 OMEPRAZOLE 793
8 FUROSEMIDE 686
9 LISINOPRIL 579
See all common drugs associated with END STAGE RENAL DISEASE

END STAGE RENAL DISEASE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 COPANLISIB 18 0.1895
1 DEXLANSOPRAZOLE 2990 0.1201
2 ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE 53 0.0752
3 LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN 18 0.0629
4 MECLOFENAMATE SODIUM 2 0.0556
5 OMEPRAZOLE MAGNESIUM 4087 0.0499
6 PANTOPRAZOLE SODIUM 3624 0.0473
7 RABEPRAZOLE SODIUM 899 0.0434
8 LANSOPRAZOLE 4382 0.0425
9 BENZOIN 1 0.0417
See all drugs enriched for association with END STAGE RENAL DISEASE

END STAGE RENAL DISEASE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Tetracycline-class Drug [EPC] 119 0.0047
1 Insulin Analog [EPC] 392 0.0019
2 Stimulant Laxative [EPC] 15 0.0017
3 Nonsteroidal Anti-inflammatory Drug [EPC] 1095 0.0015
4 Angiotensin Converting Enzyme Inhibitor [EPC] 65 0.0009
5 Prostaglandin Analog [EPC] 39 0.0008
6 Antiarrhythmic [EPC] 3 0.0004
See all drug classes enriched for association with END STAGE RENAL DISEASE